Parenteral Drugs India has received an approval from Corporate Debt Restructuring (CRD) Cell, Mumbai on November 08, 2012 for final restructuring package. Necessary steps pursuant to the approval are being taken by the lenders.
PDPL is the pioneer company making 400 mg Ciprofloxacin infusion in 200 ml with 5% dextose. The I.V. fluids are packed in size ranging from 100 ml to 3 litre and dialysis solution up to 10 litres water for injection is manufactured with the help of hi-tech From-Fill-seal machine ranging from 1 ml to 10 ml.
